AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Feakes, R Sawcer, S Broadley, S Coraddu, F Roxburgh, R Gray, J Clayton, D Compston, A
Citation: R. Feakes et al., Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis, J NEUROIMM, 105(1), 2000, pp. 96-101

Authors: Feakes, R Sawcer, S Smillie, B Chataway, J Broadley, S Compston, A Clayton, D Compston, A
Citation: R. Feakes et al., No evidence for the involvement of interleukin 2 or the immunoglobulin heavy chain gene cluster in determining genetic susceptibility to multiple sclerosis, J NE NE PSY, 68(5), 2000, pp. 679-679

Authors: Chataway, J Sawcer, S Feakes, R Coraddu, F Broadley, S Gray, J Compston, A
Citation: J. Chataway et al., More evidence that founder effects exist in the European population, EUR J HUM G, 7(6), 1999, pp. 623-624

Authors: Feakes, R Sawcer, S Chataway, J Coraddu, F Broadley, S Gray, J Jones, HB Clayton, D Goodfellow, PN Compston, A
Citation: R. Feakes et al., Exploring the dense mapping of a region of potential linkage in complex disease: An example in multiple sclerosis, GENET EPID, 17(1), 1999, pp. 51-63

Authors: Chataway, J Sawcer, S Sherman, D Hobart, M Fernie, B Coraddu, F Feakes, R Broadley, S Gray, J Hywel, BJD Jones, HB Clayton, D Goodfellow, PN Compston, A
Citation: J. Chataway et al., No evidence for association of multiple sclerosis with the complement factors C6 and C7, J NEUROIMM, 99(1), 1999, pp. 150-156

Authors: Chataway, J Sawcer, S Feakes, R Coraddu, F Broadley, S Jones, HB Clayton, D Gray, J Goodfellow, PN Compston, A
Citation: J. Chataway et al., A screen of candidates from peaks of linkage: evidence for the involvementof myeloperoxidase in multiple sclerosis, J NEUROIMM, 98(2), 1999, pp. 208-213

Authors: Feakes, R Chataway, J Sawcer, S Jones, HB Clayton, D Goodfellow, PN Compston, A
Citation: R. Feakes et al., Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene cluster, ANN NEUROL, 44(6), 1998, pp. 984-984
Risultati: 1-7 |